Suppr超能文献

相似文献

1
The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders.
Front Pharmacol. 2014 Apr 21;5:81. doi: 10.3389/fphar.2014.00081. eCollection 2014.
2
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
J Neurochem. 2016 Oct;139 Suppl 1:179-197. doi: 10.1111/jnc.13425. Epub 2016 Feb 10.
3
Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012.
4
The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System.
Front Neurosci. 2019 Jan 22;13:15. doi: 10.3389/fnins.2019.00015. eCollection 2019.
5
Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology.
Oxid Med Cell Longev. 2018 Jan 31;2018:2850341. doi: 10.1155/2018/2850341. eCollection 2018.
7
Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
Neurol Res. 2017 Jan;39(1):73-82. doi: 10.1080/01616412.2016.1251711. Epub 2016 Nov 3.
8
Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.
Front Neurosci. 2017 Jan 19;11:3. doi: 10.3389/fnins.2017.00003. eCollection 2017.
9
Iron-responsive-like elements and neurodegenerative ferroptosis.
Learn Mem. 2020 Aug 17;27(9):395-413. doi: 10.1101/lm.052282.120. Print 2020 Sep.
10
Autophagy and apoptosis dysfunction in neurodegenerative disorders.
Prog Neurobiol. 2014 Jan;112:24-49. doi: 10.1016/j.pneurobio.2013.10.004. Epub 2013 Nov 6.

引用本文的文献

3
Interaction between Hemin and Prion Peptides: Binding, Oxidative Reactivity and Aggregation.
Int J Mol Sci. 2020 Oct 13;21(20):7553. doi: 10.3390/ijms21207553.
4
Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment.
Antioxidants (Basel). 2020 Aug 3;9(8):700. doi: 10.3390/antiox9080700.
5
Iron Redox Chemistry and Implications in the Parkinson's Disease Brain.
Oxid Med Cell Longev. 2019 Oct 9;2019:4609702. doi: 10.1155/2019/4609702. eCollection 2019.
7
Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology.
Oxid Med Cell Longev. 2018 Jan 31;2018:2850341. doi: 10.1155/2018/2850341. eCollection 2018.
9
Iron-Restricted Diet Affects Brain Ferritin Levels, Dopamine Metabolism and Cellular Prion Protein in a Region-Specific Manner.
Front Mol Neurosci. 2017 May 17;10:145. doi: 10.3389/fnmol.2017.00145. eCollection 2017.
10
Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial Damage.
Antioxid Redox Signal. 2017 Sep 20;27(9):567-582. doi: 10.1089/ars.2016.6848. Epub 2017 Mar 3.

本文引用的文献

1
Targeting chelatable iron as a therapeutic modality in Parkinson's disease.
Antioxid Redox Signal. 2014 Jul 10;21(2):195-210. doi: 10.1089/ars.2013.5593. Epub 2014 Feb 6.
2
Iron accumulates in Huntington's disease neurons: protection by deferoxamine.
PLoS One. 2013 Oct 11;8(10):e77023. doi: 10.1371/journal.pone.0077023. eCollection 2013.
3
The amyloid precursor protein (APP) does not have a ferroxidase site in its E2 domain.
PLoS One. 2013 Aug 19;8(8):e72177. doi: 10.1371/journal.pone.0072177. eCollection 2013.
4
Heme prevents amyloid beta peptide aggregation through hydrophobic interaction based on molecular dynamics simulation.
Phys Chem Chem Phys. 2013 Sep 7;15(33):14098-106. doi: 10.1039/c3cp52354c. Epub 2013 Jul 18.
5
Iron metabolism in the CNS: implications for neurodegenerative diseases.
Nat Rev Neurosci. 2013 Aug;14(8):551-64. doi: 10.1038/nrn3453. Epub 2013 Jul 3.
6
Heme binding induces dimerization and nitration of truncated β-amyloid peptide Aβ16 under oxidative stress.
Angew Chem Int Ed Engl. 2013 Jul 29;52(31):8041-4. doi: 10.1002/anie.201302989. Epub 2013 Jun 20.
7
Prion protein regulates iron transport by functioning as a ferrireductase.
J Alzheimers Dis. 2013;35(3):541-52. doi: 10.3233/JAD-130218.
8
Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.
PLoS One. 2013;8(3):e57904. doi: 10.1371/journal.pone.0057904. Epub 2013 Mar 1.
9
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease.
Ann Neurol. 2013 Apr;73(4):554-9. doi: 10.1002/ana.23817. Epub 2013 Feb 19.
10
A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.
Antioxid Redox Signal. 2013 Nov 10;19(14):1662-75. doi: 10.1089/ars.2012.5032. Epub 2013 Apr 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验